Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Payden & Rygel Taps Fellow Californian To Subadvise Target-Date Funds Not Rated 0.0 Email Routing List Email & Route  Print Print
Monday, July 16, 2007

Payden & Rygel Taps Fellow Californian To Subadvise Target-Date Funds

News summary by MFWire's editors

Payden & Rygel has rolled out target maturity funds that make use of the investment research of Santa Monica-based Wilshire Funds Management. The Payden/Wilshire Longevity Funds consist of four funds that come with maturity dates ranging from 2010 to 2040. Gregory Brown, principal at Los Angeles-based Payden & Rygel, said the new funds differ from other target-date products in the market in that they invest portfolios "more dynamically after the retirement date is reached."


LOS ANGELES, July 16 /PRNewswire-FirstCall/ -- Payden & Rygel today announced the launch of an innovative series of target maturity funds utilizing the investment research of Wilshire Funds Management, the global investment management business unit of Wilshire Associates Incorporated.

The Payden/Wilshire Longevity Funds consist of four target maturity funds that are designed to take investors through retirement rather than just to retirement. The four new funds are: 2010, 2020, 2030 and 2040. Target maturity funds have become increasingly popular in recent years, particularly as investment options within 401(k) plans and other defined contribution retirement vehicles. The Payden/Wilshire Longevity Funds represent an improvement to current target maturity offerings, differing in a number of key ways from most of the competition.

"Up until now, most target maturity funds have been designed to manage retirement assets for individuals until they reach their retirement age, but not afterwards," said Gregory P. Brown, CFA, principal at Payden & Rygel and the firm's lead in launching the new fund family. "This is not just another target retirement product. The Payden/Wilshire Longevity Funds elevate long-term investing far beyond current offerings by investing portfolios more dynamically after the retirement date is reached."

Wilshire's research on current offerings in the target maturity fund space found that many glide paths turn conservative too quickly, while others blindly take on unacceptable risk, disregarding the investor's liabilities and funding status. Recognizing these limitations, Payden has developed the Payden/Wilshire Longevity Funds to manage participant portfolios for a lifetime, not just to a target retirement date.

"By incorporating key principals from the defined benefit world, carefully mapping the journey from capital appreciation to capital preservation, and employing a unique asset allocation approach that utilizes 'surplus optimization' we believe we've pioneered a new path in the defined contribution marketplace," says Greg Brown.

The blending of the traditional asset-only efficient frontier with the liability-aware surplus frontier is a proprietary technique developed by Wilshire. The surplus frontier is the curve that gives preference to asset classes that will maximize the likelihood of having a surplus starting at retirement. The asset frontier is best suited early in a participant's investment horizon when capital appreciation is critical; while the surplus frontier accounts for later in the cycle nearing and during retirement when the risk of a catastrophic loss can mean the difference between a shortfall or surplus. By effectively blending both frontiers to create a modified approach, participants' accounts are carefully moved from capital accumulation to capital preservation at the appropriate times.

The Payden/Wilshire relationship draws upon the relative strengths of each firm, providing investors with a true one-step solution backed by global investment management capabilities and leading quantitative investment analysis.

"Working with Payden is a natural fit," noted Lawrence E. Davanzo, senior managing director, Wilshire Associates and head of Wilshire Funds Management. "The organizations compliment each other and we see great potential for the Longevity Funds as a new offering in the 401(k) plan sponsor world."

The two firms share responsibilities based on their core capabilities. Payden will lead the distribution and servicing effort for the Longevity Funds, focusing on financial intermediaries and third party administrators in the defined contribution market. Wilshire will serve as sub-advisor, responsible for construction of the portfolios, including the asset allocation, the selection of the underlying investments, and the ongoing adjustments to the glide path.

The funds are designed for investors expecting to reach the age of 65 near the year indicated in the name of the fund. Each Longevity Fund operates with a fund of funds structure that invests in underlying funds, including Payden fund offerings and other core and specialty options, ETFs, and individual securities.

About Payden & Rygel

Payden & Rygel (payden.com) is one of the largest global independent investment managers in the U.S., with more than $50 billion in assets under management. Since 1983, the firm has advised corporations, foundations, endowments, pension plans, public funds and individual investors on their overall investment strategies. Payden & Rygel offers a full array of investment strategies, including U.S. and global fixed-income and equity, as well as leading edge absolute-return strategies. Headquartered in Los Angeles with offices in Phoenix, London, Dublin, Frankfurt and Hong Kong, Payden & Rygel is adviser to the Paydenfunds family of U.S.-based mutual funds and to the firm's Irish-domiciled funds. 

Edited by: Armie Margaret Lee


Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2025: Q1
2024: Q4Q3Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly


  1. MMI webinar - Enhancing the Advisor Experience, January 16
  2. MFDF webinar - AI and Fund Compliance, January 21
  3. MFDF In Focus - In Focus: Small Boards' Use of Skills Matrices, January 22
  4. IDC webinar - SEC Enforcement Trends: What Fund Directors Should Know, January 23
  5. ICI webinar - Legal and Compliance Career Opportunities in the Asset Management Industry, January 24
  6. FSI OneVoice 2025, Jan 27-29
  7. MFDF 2025 Directors' Institute, Jan 27-29
  8. Nicsa webinar - An Intro to Irish and Luxembourg Investment Platforms for US Asset Managers, January 29
  9. WE South - Dallas | Texas Stock Exchange, Politics, & Product Development, January 30
  10. 2025 ICI Innovate, Feb 3-5
  11. Nicsa webinar - AI In Operations: Boosting Productivity for Wealth & Asset Management Firms, February 5
  12. MFDF In Focus: Understanding Distribution - What the Data Can Tell You, February 6
  13. MFDF Director Discussion Series - Open Forum, February 10
  14. MFDF Director Discussion Series - Open Forum, February 11
  15. MMI Darden-in-Residence II, Feb 24-6
  16. 2025 MMI RIA Forum, February 27
  17. IDC Core Responsibilities of Fund Directors, February 27
  18. Citywire Scottsdale CIO Summit 2025, Feb 27-28
  19. Expect Miracles In Manhattan 2025, February 27
  20. T3 Technology Conference 2025, Mar 3-6
  21. IMEA Distribution Intelligence Summit, Mar 4-5
  22. Nicsa 2025 Strategic Leadership Forum, Mar 5-7
  23. Citywire Pro Buyer New York Due Diligence Retreat 2025, Mar 6-7
  24. MFDF 2025 Fund Governance & Regulatory Insights Conference, Mar 6-7
  25. MFDF 15(c) White Paper Webinar Series: Part 3 - Gartenberg Factors Analysis and Challenges, March 12
  26. ICI Investment Management Conference, Mar 16-19




©All rights reserved to InvestmentWires, Inc. 1997-2025
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use